These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 14612542)
1. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I. Antony S; Jayaraman M; Laco G; Kohlhagen G; Kohn KW; Cushman M; Pommier Y Cancer Res; 2003 Nov; 63(21):7428-35. PubMed ID: 14612542 [TBL] [Abstract][Full Text] [Related]
2. Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison. Antony S; Kohlhagen G; Agama K; Jayaraman M; Cao S; Durrani FA; Rustum YM; Cushman M; Pommier Y Mol Pharmacol; 2005 Feb; 67(2):523-30. PubMed ID: 15531731 [TBL] [Abstract][Full Text] [Related]
3. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin. Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line. Urasaki Y; Laco GS; Pourquier P; Takebayashi Y; Kohlhagen G; Gioffre C; Zhang H; Chatterjee D; Pantazis P; Pommier Y Cancer Res; 2001 Mar; 61(5):1964-9. PubMed ID: 11280753 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids. Fox BM; Xiao X; Antony S; Kohlhagen G; Pommier Y; Staker BL; Stewart L; Cushman M J Med Chem; 2003 Jul; 46(15):3275-82. PubMed ID: 12852757 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine. Antony S; Theruvathu JA; Brooks PJ; Lesher DT; Redinbo M; Pommier Y Nucleic Acids Res; 2004; 32(18):5685-92. PubMed ID: 15498925 [TBL] [Abstract][Full Text] [Related]
8. Persistence of camptothecin analog-topoisomerase I-DNA ternary complexes: a molecular dynamics study. Siu FM; Che CM J Am Chem Soc; 2008 Dec; 130(52):17928-37. PubMed ID: 19035632 [TBL] [Abstract][Full Text] [Related]
9. Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen. Pommier Y; Kohlhagen G; Wu C; Simmons DT Biochemistry; 1998 Mar; 37(11):3818-23. PubMed ID: 9521701 [TBL] [Abstract][Full Text] [Related]
10. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. Staker BL; Feese MD; Cushman M; Pommier Y; Zembower D; Stewart L; Burgin AB J Med Chem; 2005 Apr; 48(7):2336-45. PubMed ID: 15801827 [TBL] [Abstract][Full Text] [Related]
11. Effect of E-ring modifications in camptothecin on topoisomerase I inhibition: a quantum mechanics treatment. Xiao X; Cushman M J Org Chem; 2005 Nov; 70(23):9584-7. PubMed ID: 16268636 [TBL] [Abstract][Full Text] [Related]
12. Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance. Antony S; Agama KK; Miao ZH; Takagi K; Wright MH; Robles AI; Varticovski L; Nagarajan M; Morrell A; Cushman M; Pommier Y Cancer Res; 2007 Nov; 67(21):10397-405. PubMed ID: 17974983 [TBL] [Abstract][Full Text] [Related]
13. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site. Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241 [TBL] [Abstract][Full Text] [Related]
14. Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity. Antony S; Agama KK; Miao ZH; Hollingshead M; Holbeck SL; Wright MH; Varticovski L; Nagarajan M; Morrell A; Cushman M; Pommier Y Mol Pharmacol; 2006 Sep; 70(3):1109-20. PubMed ID: 16798938 [TBL] [Abstract][Full Text] [Related]
15. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517. Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons. Strumberg D; Pommier Y; Paull K; Jayaraman M; Nagafuji P; Cushman M J Med Chem; 1999 Feb; 42(3):446-57. PubMed ID: 9986716 [TBL] [Abstract][Full Text] [Related]
17. Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNA. Chourpa I; Riou JF; Millot JM; Pommier Y; Manfait M Biochemistry; 1998 May; 37(20):7284-91. PubMed ID: 9585542 [TBL] [Abstract][Full Text] [Related]
18. Activation of camptothecin derivatives by conjugation to triple helix-forming oligonucleotides. Arimondo PB; Laco GS; Thomas CJ; Halby L; Pez D; Schmitt P; Boutorine A; Garestier T; Pommier Y; Hecht SM; Sun JS; Bailly C Biochemistry; 2005 Mar; 44(11):4171-80. PubMed ID: 15766244 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors. Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay. Morrell A; Jayaraman M; Nagarajan M; Fox BM; Meckley MR; Ioanoviciu A; Pommier Y; Antony S; Hollingshead M; Cushman M Bioorg Med Chem Lett; 2006 Aug; 16(16):4395-9. PubMed ID: 16750365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]